Reuthebuch Oliver, Häussler Achim, Genoni Michele, Tavakoli Reza, Odavic Dragan, Kadner Alexander, Turina Marko
Clinic for Cardiovascular Surgery, University Hospital Zürich, Rämistrasse 100, CH-8091 Zürich, Switzerland. oliver.reuthebuch@chi/usz.ch
Chest. 2004 Feb;125(2):418-24. doi: 10.1378/chest.125.2.418.
Off-pump coronary artery bypass grafting may decrease operative morbidity when compared to on-pump bypass grafting; however, it is technically demanding and thus quality control is essential. This study assesses the clinical feasibility of a new, indocyanine green (ICG)-based imaging system (SPY; Novadaq Technologies; Toronto, ON, Canada) to monitor the quality of anastomoses and grafts in off-pump revascularization.
Thirty-eight consecutive patients undergoing nonemergent coronary artery bypass grafting without the use of extracorporeal circulation at two Swiss cardiac surgery clinics were included. On completion of bypass grafts, the quality of the grafts was assessed using the ICG-based imaging system. The imaging device comprises an 806-nm laser light source that is used to cause ICG to fluoresce and a near infrared-sensitive charged couple device videocamera that is used to capture the fluorescence images. ICG was administered through the central venous line, and images were acquired during the first pass of the ICG through the field of view. Graft flow (qualitative) and the quality of the grafts and anastomoses were assessed intraoperatively.
Between March 2002 and September 2002, a total of 38 patients (26 men and 12 women; mean +/- SD age, 64.6 +/- 10.5 years; body mass index, 27.1 +/- 2.9) underwent surgery and imaging at two institutions. One hundred seven of 124 grafts (45 arteries and 62 veins) were analyzed. Seventeen grafts could not be assessed due to difficulties in positioning. The imaging system was easy to handle, and no adverse reactions to ICG were observed. Four of the 107 grafts imaged required revision (three anastomotic constrictions and one graft dissection). Each imaging sequence required approximately 1.25 to 2.5 mg of ICG. The images were equivalent to angiography without the need for radiographs and catheter insertion. In addition, the course of coronaries that would otherwise be difficult to locate in obese patients could be detected using the imaging system. Biochemical and ECG data demonstrated an absence of intraoperative or postoperative myocardial damage, and no liver enzyme elevation or renal dysfunction.
This study supports the clinical utility of a ICG-based imaging system for the assessment of the quality of bypass grafts, which appears to be safe and simple to use.
与体外循环冠状动脉搭桥术相比,非体外循环冠状动脉搭桥术可能会降低手术发病率;然而,该技术要求较高,因此质量控制至关重要。本研究评估了一种基于吲哚菁绿(ICG)的新型成像系统(SPY;加拿大安大略省多伦多市诺瓦达克技术公司)在非体外循环血运重建术中监测吻合口和移植物质量的临床可行性。
纳入了瑞士两家心脏外科诊所连续38例接受非急诊冠状动脉搭桥术且未使用体外循环的患者。完成搭桥术后,使用基于ICG的成像系统评估移植物质量。该成像设备包括一个用于使ICG发出荧光的806纳米激光光源和一个用于采集荧光图像的近红外敏感电荷耦合器件摄像机。ICG通过中心静脉导管注入,在ICG首次通过视野期间采集图像。术中评估移植物血流(定性)以及移植物和吻合口的质量。
2002年3月至2002年9月期间,共有38例患者(26例男性和12例女性;平均±标准差年龄,64.6±10.5岁;体重指数,27.1±2.9)在两家机构接受了手术和成像检查。对124个移植物中的107个(45条动脉和62条静脉)进行了分析。由于定位困难,17个移植物无法评估。该成像系统易于操作,未观察到对ICG的不良反应。成像的107个移植物中有4个需要修复(3个吻合口狭窄和1个移植物剥离)。每个成像序列大约需要1.25至2.5毫克ICG。这些图像等同于血管造影,无需进行X光片检查和插入导管。此外,使用该成像系统可以检测出肥胖患者中原本难以定位的冠状动脉走行。生化和心电图数据显示术中或术后无心肌损伤,也无肝酶升高或肾功能障碍。
本研究支持基于ICG的成像系统在评估搭桥移植物质量方面的临床实用性,该系统似乎安全且易于使用。